RaQualia Pharma Inc. provided consolidated earnings guidance for the full year ending December 31, 2021. For the year, the company expects net sales of JPY 2,246 million, operating profit of JPY 61million, profit attributable to owners of the parent of JPY 118 million JPY 5.65 per share.